AI Analysis | Feedback

Herbalife, but focused on cellular health and anti-aging supplements.

A multi-level marketing (MLM) company in the wellness and skincare sector, similar to Amway or Herbalife.

AI Analysis | Feedback

• Protandim Synergizers: A line of dietary supplements designed to activate specific cellular pathways (Nrf2, Nrf1, NAD) to combat oxidative stress, mitochondrial decline, and support cellular health.
• TrueScience Skincare: A collection of topical skincare products utilizing nutrigenomic technology to improve skin health and appearance.
• PhysIQ Weight Management: A system of dietary supplements and meal replacements aimed at supporting healthy weight loss and metabolism.
• Targeted Nutrition & Pet Health: Includes specialized supplements for energy (Axio), daily wellness (e.g., probiotics, omega-3s, vitamins), and a line of supplements formulated for canine health.

AI Analysis | Feedback

• Independent Distributors: These individuals are the core of Lifevantage's sales force and its primary direct customers. They purchase products directly from Lifevantage for their personal consumption, to maintain inventory for resale to end-consumers, and to qualify for commissions and bonuses by building their own sales teams and achieving specific sales volumes.
• Preferred Customers: These individuals enroll directly with Lifevantage for recurring product shipments (subscriptions), often receiving discounted pricing or other benefits. They are primarily consumers who commit to regular, automated purchases of Lifevantage products for their personal use.
• Direct Retail Customers: These are individuals who make one-time purchases of Lifevantage products directly through the company's official website or other direct company channels, without signing up for a subscription or becoming an independent distributor. While their purchase might eventually be credited to a distributor, the initial transaction is directly with Lifevantage.

AI Analysis | Feedback

AI Analysis | Feedback

Steve Fife, President and Chief Executive Officer

Steve Fife has over three decades of financial leadership experience. He joined LifeVantage as Chief Financial Officer in March 2017, was appointed Interim Chief Executive Officer in September 2020, and became permanent CEO in February 2021. Prior to LifeVantage, he served as Chief Financial Officer and Chief Operating Officer at Evidera, Inc., a private equity-sponsored professional services firm. He also held CFO positions at publicly traded companies such as Active Power, Inc. and LECG, and held senior financial roles at Gilead Sciences, Amkor Technologies, and JDS Uniphase. He began his career as a Senior Audit Manager at Deloitte & Touche. He is a Certified Public Accountant (inactive) and holds a Bachelor of Science degree in Accounting from Brigham Young University.

Carl Aure, Chief Financial Officer

Carl Aure was appointed Chief Financial Officer of LifeVantage in October 2021. He possesses over 24 years of finance and accounting experience, including more than 15 years in the direct selling industry. Before joining LifeVantage, he served as Chief Accounting Officer for New Age, Inc., a social selling company. He joined New Age in 2018 as Senior Vice President, Corporate Controller, following its acquisition of Morinda Holdings, Inc., where he held various finance and accounting roles from 2005 to 2018. Earlier in his career, he spent eight years at KPMG, LLP, most recently as Senior Manager. He is a Certified Public Accountant and holds a Master of Professional Accountancy from the University of Utah.

Julie Boyster, Chief Marketing Officer

Julie Boyster has served as Chief Marketing Officer since January 2022. She is recognized as a strategic marketer with a strong background in direct sales, having previously led product marketing, communications, and digital teams for Plexus Worldwide, where she played a key role in the company's hypergrowth and digital transformation. Ms. Boyster holds a Bachelor of Arts degree in Journalism and Mass Communication from Arizona State University.

Kristen Cunningham, Chief Sales Officer

Kristen Cunningham has been LifeVantage's Chief Sales Officer since June 2022, following her tenure as Interim Chief Sales Officer and various leadership roles within the sales organization since November 2020. Prior to LifeVantage, she served as Director of Business Development and held other sales leadership positions at Shaklee Corporation from August 2011 to October 2020. From 2006 to 2011, she worked in distributor support and sales at Nu Skin Enterprises. Ms. Cunningham holds a Bachelor of Arts degree in Communications and Media Studies from Brigham Young University.

Michelle Oborn, Chief People Officer

Michelle Oborn has served as Chief People Officer since August 2022 and has been a pivotal leader in the human resources department at LifeVantage since 2009. She also directs LifeVantage Legacy, the company's non-profit organization. Before joining LifeVantage, Ms. Oborn was the Human Resources Manager at Zrii International, a direct selling wellness company. From 2005 to 2008, she worked as a litigation and employment paralegal at Wrona Law Offices. She holds a degree in Political Science from the University of Utah.

AI Analysis | Feedback

The public company LifeVantage (symbol: LFVN) faces several key risks to its business operations and financial performance:

1. Reliance on a Direct Selling Model: LifeVantage primarily operates through a direct selling network of independent consultants, which presents multiple inherent risks. These include the potential for non-compliance by independent consultants with legal requirements or company policies, changes to consultant compensation plans, and potential negative publicity or regulatory scrutiny associated with the direct selling model. This model's pressures can also challenge profit margins.
2. Intense Competition in the Dietary Supplement and Personal Care Markets: LifeVantage operates in highly competitive dietary supplement and personal care markets. The company's ability to compete effectively against numerous other players, some of which may have greater financial resources or market share, could materially impact its results of operations and financial condition.
3. Dependence on Key Products and Associated Product Risks: The company depends on a limited number of products for a significant portion of its revenue. This concentration increases the business's vulnerability if any of these key products face issues. Furthermore, the business is susceptible to product liability claims and the risk of product recalls, which could lead to significant financial costs and reputational damage.

AI Analysis | Feedback

The increasing prevalence and market penetration of direct-to-consumer (DTC) wellness and supplement brands poses a clear emerging threat to Lifevantage. These DTC companies leverage sophisticated digital marketing, e-commerce platforms, and subscription models to offer scientifically-backed supplements, including those focused on anti-aging, cellular health, and nutrigenomics principles, directly to consumers. This business model bypasses the traditional multi-level marketing (MLM) distribution network, enabling potentially lower cost structures, greater pricing flexibility, and a more streamlined customer experience. Consumers are increasingly drawn to the transparency, convenience, and direct relationship offered by DTC brands, which directly erodes the unique distribution advantage and customer acquisition strategy historically employed by Lifevantage and other MLM companies in the health and wellness sector.

AI Analysis | Feedback

LifeVantage (LFVN) operates in several addressable markets with the following estimated sizes:

• Nutraceuticals (Dietary Supplements): The global nutraceuticals market, which includes dietary supplements, was valued at approximately USD 451.8 billion to USD 591.1 billion in 2024. It is projected to reach between USD 877.8 billion and USD 986.85 billion by 2033-2035. The United States accounted for over 27.9% of the global nutraceuticals market in 2024.
• Weight Management Products and Services: The global weight management market was estimated to be between USD 144.6 billion and USD 562.9 billion in 2024. It is projected to grow to approximately USD 298.66 billion to USD 881.1 billion by 2030-2033. The global market for weight management supplements alone was valued at USD 5.2 billion in 2024 and is projected to reach USD 22.2 billion by 2035. The U.S. weight loss industry was valued at USD 3.4 billion in 2023.
• Anti-Aging Products (Skincare): The global anti-aging products market was valued at approximately USD 48.20 billion to USD 55.8 billion in 2024. It is projected to reach between USD 80.61 billion and USD 108.5 billion by 2030-2033. North America held 30.4% of the global anti-aging products market revenue in 2024.
• Skincare Products: The global skincare products market was valued at approximately USD 115.65 billion to USD 171.05 billion in 2024. It is projected to grow to between USD 194.05 billion and USD 260.61 billion by 2032-2033. The U.S. skincare market is projected to reach an estimated value of USD 30.42 billion by 2032.
• Hair Care Products: The global hair care market was valued at approximately USD 90.5 billion to USD 106.91 billion in 2024. It is projected to reach between USD 128.7 billion and USD 213.47 billion by 2032-2034. North America dominated the market, holding over 35.0% of the market share in 2024, with the U.S. contributing an estimated USD 22.2 billion in revenue in 2024.

AI Analysis | Feedback

Here are 3-5 expected drivers of future revenue growth for LifeVantage (LFVN) over the next 2-3 years:

1. Continued Growth and International Expansion of the MindBody GLP-1 System: The MindBody GLP-1 system has been a significant driver of revenue growth, particularly in the U.S. market, since its launch. LifeVantage is actively expanding this product internationally, with launches in Japan, Australia, New Zealand, Mexico, Europe, the UK, Thailand, the Philippines, Taiwan, and Canada planned or already executed through fiscal year 2026. This global rollout is anticipated to be a primary contributor to future revenue increases.
2. Strategic Acquisition of LoveBiome: The acquisition of LoveBiome is expected to drive growth by expanding LifeVantage's product offerings in the rapidly growing gut microbiome health market. This acquisition also provides geographic expansion, particularly in the U.S., Taiwan, and Europe, and is projected to contribute to revenue in fiscal year 2026.
3. Expansion and Enhancement of the Direct Selling Model and Consultant Base (LV360 and Evolve Compensation Plan): LifeVantage is focusing on increasing its active customer and independent consultant base through its LV360 initiatives and the Evolve Compensation Plan. This modernized compensation plan, which offers various income opportunities and supports both traditional sellers and micro-influencers, is being expanded to new international markets such as the Philippines, Taiwan, Hong Kong, and Singapore, with the aim of attracting and retaining consultants and customers to drive sales growth.
4. Launch of New Products and Product Stacks: Beyond the MindBody GLP-1 system, LifeVantage continues its strategy of product development and innovation. The company has teased the launch of new weight loss products and introduces "Health Stacks" (product bundles) to provide synergistic health benefits and drive sales.

AI Analysis | Feedback

Share Repurchases

• LifeVantage is authorized to repurchase up to $60.0 million of its outstanding shares through December 31, 2026, a program that was last amended on June 12, 2023.
• In fiscal year 2025 (ended June 30, 2025), the company repurchased 0.3 million shares for an aggregate price of $3.1 million.
• In fiscal year 2024 (ended June 30, 2024), LifeVantage repurchased 1.0 million shares for $6.4 million. [cite: 17 (previous search)]
• As of September 30, 2025, approximately $16.7 million remained under the current share repurchase program authorization. [cite: 8 (previous search)]

Share Issuance

• LifeVantage issued 0.5 million shares of common stock under company stock plans during the three months ended September 30, 2025.
• During the three months ended September 30, 2024, 0.1 million shares of common stock were issued under company stock plans.
• Stockholders approved amendments to the 2017 Plan in November 2022 and November 2023, increasing the number of shares available for issuance under the plan by 1,052,000 and 1,138,000 shares, respectively. [cite: 1 (previous search)]

Inbound Investments

• No significant inbound investments by third parties have been reported for the last 3-5 years.

Outbound Investments

• On October 1, 2025, LifeVantage completed the acquisition of critical assets of LoveBiome. [cite: 1 (previous search)]
• The company's $5.0 million revolving credit facility was amended to permit its use for acquisitions. [cite: 1 (previous search)]

Capital Expenditures

• Purchases of property and equipment, which represent capital expenditures, amounted to approximately $439 thousand for the three months ended September 30, 2025.
• For the three months ended September 30, 2024, capital expenditures for purchases of property and equipment were approximately $349 thousand.